Applied DNA Sciences Inc APDN:NASDAQ

Last Price$0.71NASDAQ Previous Close - Last Trade as of 3:59PM ET 7/01/22

Today's Change-0.03(4.09%)
Bid (Size)$0.71 (3)
Ask (Size)$0.74 (24)
Day Low / High$0.67 - 0.76
Volume1.4 M

View Biotechnology IndustryPeer Comparison as of 07/01/2022


Applied DNA Sciences Inc ( NASDAQ )

Price: $0.71
Change: -0.03 (4.09%)
Volume: 1.4 M
3:59PM ET 7/01/2022

InVivo Therapeutics Holdings Corp ( NASDAQ )

Price: $4.19
Change: +0.14 (3.45%)
Volume: 5.0 K
3:24PM ET 7/01/2022

PolarityTE Inc ( NASDAQ )

Price: $1.52
Change: +0.07 (4.83%)
Volume: 80.6 K
4:00PM ET 7/01/2022

Islet Holdings Inc ( OTC )

Price: $0.03
Change: 0.00 (0.00%)
Volume: 100.00
9:39AM ET 9/24/2021

Benchmark Energy Corp ( OTC )

Price: $0.04
Change: 0.00 (0.00%)
Volume: 167.00
11:50AM ET 6/01/2022

Read more news Recent News

Applied DNA Sciences Says Preclinical Data Backs Use of Its Platform to Make Veterinary Cancer Vaccines
12:33PM ET 6/06/2022 MT Newswires

Applied DNA Sciences (APDN) said Monday preclinical animal data published in a peer-reviewed publication backs the use of its LinearDNA platform to make...

--HC Wainwright Adjusts Applied DNA Sciences' Price Target to $4 from $6, Keeps Buy Rating
9:06AM ET 5/16/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (APDN) APPLIED DNA SCIENCES Posts Q2 Revenue $6.1M, vs. Street Est of $4.5M
4:23PM ET 5/12/2022 MT Newswires


Applied DNA Sciences Unit Wins COVID-19 Testing Services Contract From NYC Client
10:33AM ET 4/06/2022 MT Newswires

Applied DNA Sciences (APDN) said Wednesday an undisclosed New York City-based investment management firm awarded the company's Applied DNA Clinical Labs...

Company Profile

Business DescriptionApplied DNA Sciences, Inc. engages in the developing and marketing DNA-based technology solutions utilizing LinearDNA, large-scale polymerase chain reaction (PCR) based manufacturing platform. Its proprietary platform produces large quantities of DNA for use in nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets (Biotherapeutic Contract Research and Manufacturing) and for supply chain security, anti-counterfeiting and anti-theft technology purposes. The company was founded in 1983 and is headquartered in Stony Brook, NY. View company web site for more details
Address50 Health Sciences Drive
Stony Brook, New York 11790
Number of Employees59
Recent SEC Filing05/12/20228-K
Chairman, President & Chief Executive OfficerJames A. Hayward
Chief Operating OfficerJudy Murrah
Chief Financial Officer & ControllerBeth M. Jantzen
Associate Director-ProductionFrank Cipriani

Company Highlights

Price Open$0.74
Previous Close$0.74
52 Week Range$0.67 - 8.10
Market Capitalization$5.3 M
Shares Outstanding7.5 M
SectorHealth Technology
Next Earnings Announcement08/11/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.88
Beta vs. S&P 500N/A
Revenue$3.9 M
Net Profit Margin-95.93%
Return on Equity-135.14%

Analyst Ratings as of 02/12/2021

Consensus RecommendationConsensus Icon
Powered by Factset